GPC and Cytovia in oncology deal

GPC Biotech (NMarkt:GPC) will use its Reverse Genomics technology to analyze the mode of action of an apoptosis-inducing compound from Cytovia (San Diego, Calif.). Cytovia, a subsidiary of Maxim (MAXM...